Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
Neutrogena®, part of Kenvue Inc. (NYSE: KVUE), announced multi-year partnerships with dermatologists Dr. Dhaval Bhanusali and Dr. Muneeb Shah to enhance its dermatological beauty offerings. As Global Innovation Partners, they will focus on three key areas: innovation acceleration, consumer engagement, and dermatologist collaboration. The partnership aims to advance clinical science, improve product experience, and build consumer community engagement. This initiative reinforces Neutrogena's position as America's #1 facial skincare brand and strengthens its commitment to combining beauty with scientific innovation.
Neutrogena®, parte di Kenvue Inc. (NYSE: KVUE), ha annunciato collaborazioni pluriennali con i dermatologi Dr. Dhaval Bhanusali e Dr. Muneeb Shah per migliorare la sua offerta di bellezza dermatologica. In qualità di Partner Globali per l'Innovazione, si concentreranno su tre aree chiave: accelerazione dell'innovazione, coinvolgimento dei consumatori e collaborazione con i dermatologi. La partnership mira ad avanzare la scienza clinica, migliorare l'esperienza del prodotto e costruire un impegno della comunità di consumatori. Questa iniziativa rafforza la posizione di Neutrogena come il marchio di skincare facciale numero uno in America e consolida il suo impegno nel combinare bellezza e innovazione scientifica.
Neutrogena®, parte de Kenvue Inc. (NYSE: KVUE), anunció asociaciones plurianuales con los dermatólogos Dr. Dhaval Bhanusali y Dr. Muneeb Shah para mejorar sus ofertas de belleza dermatológica. Como Socios Globales de Innovación, se centrarán en tres áreas clave: aceleración de la innovación, involucramiento del consumidor y colaboración con dermatólogos. La asociación tiene como objetivo avanzar en la ciencia clínica, mejorar la experiencia del producto y construir un compromiso de la comunidad de consumidores. Esta iniciativa refuerza la posición de Neutrogena como la marca número uno en cuidado facial en América y fortalece su compromiso de combinar la belleza con la innovación científica.
뉴트로지나®는 켄뷰 인크. (NYSE: KVUE)의 일부로서 피부과 의사 드. 다바알 바누살리와 드. 뮤니브 샤와의 다년간의 파트너십을 발표하여 피부과 뷰티 제품을 강화할 예정입니다. 그들은 글로벌 혁신 파트너로서 세 가지 주요 분야에 집중할 것입니다: 혁신 가속화, 소비자 참여, 그리고 피부과 의사와의 협업. 이 파트너십은 임상 과학을 발전시키고, 제품 경험을 개선하며, 소비자 커뮤니티 참여를 구축하는 것을 목표로 하고 있습니다. 이 이니셔티브는 뉴트로지나가 미국 1위 페이셜 스킨케어 브랜드로서의 입지를 강화하고, 미용과 과학의 혁신을 결합하겠다는 의지를 확고히 합니다.
Neutrogena®, faisant partie de Kenvue Inc. (NYSE: KVUE), a annoncé des partenariats pluriannuels avec les dermatologues Dr. Dhaval Bhanusali et Dr. Muneeb Shah afin d'améliorer son offre de beauté dermatologique. En tant que partenaires mondiaux de l'innovation, ils se concentreront sur trois domaines clés : l'accélération de l'innovation, l'engagement des consommateurs et la collaboration avec les dermatologues. Le partenariat vise à faire progresser la science clinique, à améliorer l'expérience produit et à renforcer l'engagement de la communauté des consommateurs. Cette initiative renforce la position de Neutrogena en tant que marque de soins du visage numéro un aux États-Unis et souligne son engagement à allier beauté et innovation scientifique.
Neutrogena®, Teil von Kenvue Inc. (NYSE: KVUE), gab mehrjährige Partnerschaften mit den Dermatologen Dr. Dhaval Bhanusali und Dr. Muneeb Shah bekannt, um sein dermatologisches Schönheitsangebot zu verbessern. Als globale Innovationspartner konzentrieren sie sich auf drei Schlüsselbereiche: Innovationsbeschleunigung, Verbraucherengagement und Zusammenarbeit mit Dermatologen. Ziel der Partnerschaft ist es, die klinische Wissenschaft voranzutreiben, das Produkterlebnis zu verbessern und das Engagement der Verbrauchergemeinschaft zu stärken. Diese Initiative festigt Neutrogenas Position als die Nummer eins der Gesichts-Hautpflege-Marke in Amerika und stärkt das Engagement des Unternehmens, Schönheit mit wissenschaftlicher Innovation zu verbinden.
- Partnership with two leading dermatologists strengthens Neutrogena's market position
- Strategic expansion in dermatological expertise to drive product innovation
- Reinforcement of market leadership as #1 facial skincare brand in America
- None.
Insights
This partnership, while innovative in terms of brand positioning, has minimal direct financial impact on Kenvue's immediate business performance. The collaboration with Dr. Bhanusali and Dr. Shah primarily focuses on product development and consumer engagement - areas that could potentially influence future revenue but don't represent material news for investors.
The Neutrogena brand, while significant within Kenvue's portfolio as America's
America’s #1 facial skincare1 brand expanding and accelerating collaboration with dermatologists to foster innovation
(Photo: Business Wire)
This collaboration reinforces Neutrogena®’s commitment to fusing beauty and science to deliver advanced clinical efficacy and extraordinary product experiences. It also builds on existing partnerships with a diverse network of global dermatologists who are actively involved in product development, clinical studies, and educational initiatives. Looking ahead, Neutrogena® aims to advance the science of dermatology to better address gaps in the category and help shape the future of skincare by increasing collaboration with the dermatologist community.
“We look forward to strengthening our leadership in dermatological beauty and deepening our connections with the healthcare professional community, retailers and consumers,” said Chris Riat, Global Neutrogena® Brand Leader. “We are excited to work closely with leading experts like Dr. Bhanusali and Dr. Shah, who share our passion for advancing dermatological science and obsession with product formulation and experience.”
Dr. Bhanusali is a pivotal figure in the global skincare industry and a renowned skincare formulator.
Dr. Shah is widely recognized for his insights on consumer behavior and for successfully using social media to make dermatology accessible.
Together, they are raising the profile of dermatology and reshaping its importance in skin health and beauty.
As Global Innovation Partners, they will work with Neutrogena® in three areas:
- Innovation acceleration: partnering with the Company’s R&D teams to both advance clinical science and improve product experience
- Consumer engagement: building a proactive and engaged community of consumers and influencers
- Dermatologist collaboration: exploring new ways to partner with the dermatologist community
“From inception to the moment consumers use the products for the first time, I am proud to help Neutrogena craft the future of beauty,” said Dr. Bhanusali. “This partnership represents a true shift in skincare, one where brands truly lean into science and partner with dermatologists to better care for their patients and consumers everywhere."
“Dermatologist-led innovation is central to Neutrogena’s identity, and I’m proud to support the brand in developing next-generation solutions for our patients,” shared Dr. Shah. “Through this partnership we hope to reinforce Neutrogena's unwavering commitment to both dermatologists and patients, shaping the future of science-backed beauty."
About Kenvue
Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
About Neutrogena®
For over 90 years, Neutrogena® has made sophisticated science simple, developing solutions for everyday skincare that balance clinical efficacy with elegant aesthetics. From science-backed innovation to accessible education, we are driven by a mission to democratize skin health. Our products address skin needs across ages, skin types and tones. Neutrogena® is a brand of Kenvue Brands LLC, a subsidiary of Kenvue Inc.
1 |
Based on Nielsen sales data for the 52 weeks ending 9/7/24 |
|
2 |
Based on Dr. Shah’s combined Instagram and TikTok reach |
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding a multi-year collaboration with Dr. Muneeb Shah and Dr. Dhaval Bhanusali to deliver advanced clinical efficacy and extraordinary product experiences for the Neutrogena® brand. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates. Risks and uncertainties include, but are not limited to: the potential that the expected benefits and opportunities related to the collaboration may not be realized or may take longer to realize than expected; challenges inherent in new product development, including the uncertainty of clinical success and obtaining regulatory approvals; competition, including technological advances, new products and intellectual property attained by competitors; uncertainty of commercial success for new products; the ability of Kenvue to successfully execute strategic plans; impact of business combinations and divestitures; challenges to intellectual property; and changes in behavior and spending patterns or financial distress of consumers. A further list and descriptions of these risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031619557/en/
Melissa Witt
media@kenvue.com
Source: Kenvue
FAQ
What is the purpose of Neutrogena's new partnership announced by Kenvue (KVUE)?
Who are the dermatologists partnering with Neutrogena in this new collaboration?
What are the three main focus areas of Neutrogena's new dermatologist partnership?
